Loperamide metabolite-induced cardiomyopathy and QTc prolongation.

MLA

Bhatti, Zabeer, et al. “Loperamide Metabolite-Induced Cardiomyopathy and QTc Prolongation.” Clinical Toxicology (Philadelphia, Pa.), vol. 55, no. 7, Aug. 2017, pp. 659–61. EBSCOhost, https://doi.org/10.1080/15563650.2017.1304555.

APA

Bhatti, Z., Norsworthy, J., & Szombathy, T. (2017). Loperamide metabolite-induced cardiomyopathy and QTc prolongation. Clinical Toxicology (Philadelphia, Pa.), 55(7), 659–661. https://doi.org/10.1080/15563650.2017.1304555

Chicago

Bhatti, Zabeer, Jessica Norsworthy, and Tamas Szombathy. 2017. “Loperamide Metabolite-Induced Cardiomyopathy and QTc Prolongation.” Clinical Toxicology (Philadelphia, Pa.) 55 (7): 659–61. doi:10.1080/15563650.2017.1304555.